HEPION PHARMACEUTICALS, INC. (HEPA) Net income 2016–2025
HEPION PHARMACEUTICALS, INC. (HEPA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$8.3MFY2025 · since FY2016: -$17.0M → -$8.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.3M | +37.3% |
| FY2024 | -$13.2M | +73.0% |
| FY2023 | -$48.9M | -15.9% |
| FY2022 | -$42.2M | -29.0% |
| FY2021 | -$32.7M | -60.8% |
| FY2020 | -$20.4M | -189.2% |
| FY2019 | -$7.0M | +25.5% |
| FY2018 | -$9.4M | +36.5% |
| FY2017 | -$14.9M | +12.4% |
| FY2016 | -$17.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice